(Q34340092)

1 August 2017

1 reference

title

Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg. (English)

1 reference

1 August 2017

1 reference

J J Bergan

1

1 reference

1 August 2017

G W Schmid-Schönbein

series ordinal

2

1 reference

1 August 2017

S Takase

series ordinal

3

1 reference

1 August 2017

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

52 Suppl 1

1 reference

1 August 2017

page(s)

S43-7

1 reference

Leukocyte activation in patients with venous insufficiency

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S06

The leukocyte response to fluid stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S06

A study of valve incompetence that developed in an experimental model of venous hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S06

Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S06

Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S06

Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S06

10.1177/0003319701052001S06

21 January 2018

Identifiers

DOI

1 reference

release_cm4ylgvl25cevpbziyfaywk3gi

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cm4ylgvl25cevpbziyfaywk3gi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference